Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 8/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.41 |
| ▸ | CFD | P00746 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1372122 | 1.00 | HDAC8 (0.49) | HDAC8MEN1KMT2ANPC1S1PR1 | |
| SCHEMBL1375465 | 0.86 | CYP3A4 (0.57) | HDAC8MEN1KMT2ANPC1S1PR1 | |
| SCHEMBL1375463 | 0.86 | CYP3A4 (0.57) | HDAC8MEN1KMT2ANPC1S1PR1 | |
| SCHEMBL1374798 | 0.78 | S1PR1 (0.52) | HDAC8MEN1KMT2ANPC1S1PR1 | |
| SCHEMBL1374795 | 0.78 | S1PR1 (0.52) | HDAC8MEN1KMT2ANPC1S1PR1 | |
| SCHEMBL7728024 | 0.77 | MEN1 (0.62) | HDAC8MEN1KMT2ANPC1CYP2C9 | |
| SCHEMBL7728781 | 0.77 | MEN1 (0.62) | HDAC8MEN1KMT2ANPC1CYP2C9 | |
| SCHEMBL7728020 | 0.77 | MEN1 (0.62) | HDAC8MEN1KMT2ANPC1CYP2C9 | |
| SCHEMBL30475244 | 0.76 | CYP1A2 (0.46) | HDAC8MEN1KMT2ANPC1CYP3A4 | |
| SCHEMBL7728565 | 0.76 | MEN1 (0.51) | HDAC8MEN1KMT2ANPC1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791102-B2 | Acetanilide sphingosine-1-phosphate receptor antagonists | EXELIXIS, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-20110288076-A1 | Sphingosine-1-Phosphate Receptor Antagonists | EXELIXIS, INC. (US) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288076-A1 | Sphingosine-1-Phosphate Receptor Antagonists | S1PR1, S1PR2, S1PR3 | HDAC8 1456/4885MEN1 2389/4885KMT2A 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.